Nha Trang Vaccines And Biological Products JSC (UPCoM: BIO)
18,200
Open18,200
High18,200
Low18,200
Vol100
Market Cap.155.64
Remain Bid1,400
Remain Ask3,000
52Wk High24,100
52Wk Low16,100
52Wk Avg Vol954
Foreign Buy-
Frgn Owned(%)-
Dividend800
Dividend Yield0.04
Beta-0.88
EPS
P/E-
F P/E33.20
BVPS
P/B-
Date | Close | Change | Volume |
---|---|---|---|
03/29/2024 | 18,200 | 0 (0.00%) | 100 |
03/28/2024 | 20,500 | 300 (+1.49%) | 1,100 |
03/27/2024 | 20,200 | -200 (-0.98%) | 300 |
03/26/2024 | 20,200 | 2,200 (+12.22%) | 1,600 |
03/25/2024 | 18,000 | 400 (+2.27%) | 510 |
06/19/2023 | BIO Dividend payment in cash with 8.00% for 2022 (Record date) |
06/19/2023 | BIO Dividend payment in cash with 8.00% for 2022 |
06/20/2022 | BIO Dividend payment in cash with 3.00% for 2021 |
06/20/2022 | BIO Dividend payment in cash with 3.00% for 2021 (Record date) |
06/18/2021 | BIO Dividend payment in cash with 3.00% for 2020 |
03/25/2024 | Audited FS 2023 |
01/31/2024 | Corporate Governance Report 2023 |
07/26/2023 | Corporate Governance Report the first 6 month of 2023 |
04/27/2023 | Resolution of Annual Shareholders' Meeting 2023 |
03/29/2023 | 2023 Annual Shareholders’Meeting Documents |
Name: Nha Trang Vaccines And Biological Products JSC
Abbreviation:BIOPHARCO
Address: 26 Han Thuyen, Xuong Huan Ward Nha Trang Khanh Hoa
Telephone: (84.5) 8381 3067
Fax: (84.5) 8382 8135
Email:biopharco@dng.vnn.vn
Website:https://biopharco2.com.vn
Exchange: UPCoM
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 08/30/2018
Chartered capital: 85,620,000,000
Listed shares: 8,562,000
Shares outstanding: 8,551,500
Status: Operating
Tax code: 4200451832
Establishment license: 2329/QĐ-BYT
Issued date: 06/30/2010
Business license: 4200451832
Issued date: 07/13/2011
Main business scope:
- Producing medicines, medical chemistries, drugs, vaccines and biological products.
- Applying and transferring technologies in production of vaccines and biological product.
- Producing nutrition-food supplements and functional foods.
- 27 February 2001: Vaccines and Biological Products Company No.2 under Institute of Vaccine and Medical Biologicals was established under the Decision No.603/2001/QD-BYT issued by Ministry of Health;
- 09 January 2009: Ministry of Health issued the Decision No.72/QD-BYT on separating Vaccines and Biological Products Company No.2 from Institute of Vaccine and Medical Biologicals to become a State-owned enterprise as an independent accounting unit under Ministry of Health;
- 13 July 2011: Ministry of Health issued the Decision No.2329/QD-BYT on transforming Vaccines and Biological Products Company No.2 into Nha Trang Vaccines and Biological Products One-member Limited Company;
- 06 November 2015: Ministry of Health issued the Decision No.4735/QD-BYT on approving the equitization plan of Nha Trang Vaccines and Biological Products One-member Limited Company;
- 16 March 2016: Initial Public Offering (IPO) was launched at Hochiminh Stock Exchange (HOSE);
- 01 September 2016: Transformed into Nha Trang Vaccines and Biological Products Joint Stock Company with a charter capital of VND34.62 billion under the business registration certificate No.4200451832 issued for the first time by Khanh Hoa Department of Planning and Investment ;
- 17 May 2017: Charter capital was raised to VND85.62 billion;
- 14 September 2017: Became a public company under the Document No.6193/UBCK-GSDC issued by the State Securities Commission of Vietnam (SSC);
- 30 August 2018: Traded on the UPCOM market;
- 04/26/2024 BIO General Meeting of Shareholders for 2024
- 06/19/2023 BIO Dividend payment in cash with 8.00% for 2022 (Record date)
- 06/19/2023 BIO Dividend payment in cash with 8.00% for 2022
- 04/25/2023 BIO General Meeting of Shareholders for 2023
- 06/20/2022 BIO Dividend payment in cash with 3.00% for 2021
Items | Unit |
---|---|
Price | VND |
Volume | Shares |
Foreigner's, Yield | % |
Mkt Cap | bVND |
Financial indicators | mVND |
EPS, BVPS, Dividend | VND |
P/E, F P/E, P/B | Times |
ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.